EU Approves Daraxonrasib for Pancreatic Cancer via Accelerated Pathway
Published 2 d ago1 sourceEvidence: Reported
Fox Chase Cancer Center scientists discovered that ANO6 facilitates cholesterol uptake in pancreatic cancer cells, and blocking it slows tumor growth and reduces immunosuppression in early experiments. The finding is preliminary, based on preclinical models, and its clinical applicability remains uncertain. This opens a new avenue for treating one of the deadliest cancers.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Locations
Entities
Published 2 d ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 10 h ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Unknown